PARD3 and colorectal carcinoma: Taken together, our study demonstrated that the SLCO4A1-AS1/miR-508-3p/PARD3/autophagy signaling modulated the CRC cell proliferation, and might provide novel targets for developing CRC therapeutic strategies.